major depressive disorder

Showing NaN - NaN of 86

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

MDD Trial in United States (Vortioxetine, Placebo)

Completed
  • Major Depressive Disorder
  • Phoenix, Arizona
  • +78 more
Dec 16, 2020

MDD Trial in Puerto Rico, United States (AGO178)

Terminated
  • Major Depressive Disorder
  • Birmingham, Alabama
  • +97 more
Dec 16, 2020

MDD Trial in Puerto Rico, United States (Agomelatine (AGO178C), Placebo)

Completed
  • Major Depressive Disorder
  • Agomelatine (AGO178C)
  • Placebo
  • Birmingham, Alabama
  • +47 more
Dec 15, 2020

MDD Trial in Puerto Rico, United States (Agomelatine, paroxetine, )

Completed
  • Major Depressive Disorder
  • Phoenix, Arizona
  • +46 more
Dec 15, 2020

MDD Trial in Puerto Rico, United States (Placebo, Levomilnacipran, Fluoxetine)

Completed
  • Major Depressive Disorder
  • Placebo
  • +2 more
  • Dothan, Alabama
  • +48 more
Aug 19, 2020

MDD Trial in United States (Assay-guided treatment (AGT), Treatment-as-usual (TAU))

Completed
  • Major Depressive Disorder
  • Assay-guided treatment (AGT)
  • Treatment-as-usual (TAU)
  • Birmingham, Alabama
  • +22 more
Aug 27, 2020

MDD Trial in United States (TS-121 10 mg, TS-121 50 mg, Placebo)

Terminated
  • Major Depressive Disorder
  • TS-121 10 mg
  • +2 more
  • Little Rock, Arkansas
  • +21 more
Jul 1, 2020

Depression, MDD Trial in Canada, United States (Levomilnacipran ER, Placebo)

Completed
  • Depression
  • Major Depressive Disorder
  • Levomilnacipran ER
  • Placebo
  • Beverly Hills, California
  • +34 more
Dec 23, 2019

MDD Trial in United States (Placebo, Vilazodone)

Completed
  • Major Depressive Disorder
  • Imperial, California
  • +51 more
Dec 6, 2019

MDD Trial in Canada, United States (Vilazodone)

Completed
  • Major Depressive Disorder
  • Birmingham, Alabama
  • +55 more
Sep 10, 2019

MDD Trial in Puerto Rico, United States (Cariprazine, Antidepressant Therapy (ADT))

Completed
  • Major Depressive Disorder
  • Tucson, Arizona
  • +89 more
Jul 29, 2019

MDD Trial in Canada, United States (ALKS 5461)

Completed
  • Major Depressive Disorder
  • ALKS 5461
  • Jacksonville, Florida
  • +8 more
Aug 2, 2019

MDD Trial in Australia, Canada, United States (High Dose ALKS 5461, Low Dose ALKS 5461, Placebo)

Completed
  • Major Depressive Disorder
  • High Dose ALKS 5461
  • +2 more
  • Birmingham, Alabama
  • +48 more
Aug 2, 2019

MDD Trial in United States (Vortioxetine)

Completed
  • Major Depressive Disorder
  • Costa Mesa, California
  • +24 more
Jun 14, 2019

MDD Trial in Mexico, United States (desvenlafaxine succinate sustained release, fluoxetine, )

Completed
  • Major Depressive Disorder
  • desvenlafaxine succinate sustained release
  • +2 more
  • Dothan, Alabama
  • +42 more
Jan 2, 2019

MDD Trial in Worldwide (ALKS 5461)

Completed
  • Major Depressive Disorder
  • ALKS 5461
  • Birmingham, Alabama
  • +157 more
Nov 21, 2018

MDD Trial in National City, Orlando (Placebo, Brexpiprazole 1 mg, Brexpiprazole 3 mg)

Terminated
  • Major Depressive Disorder
  • Placebo
  • +2 more
  • National City, California
  • +1 more
Sep 18, 2018

MDD Trial in Orlando (Brexpiprazole)

Terminated
  • Major Depressive Disorder
  • Orlando, Florida
    US008
Sep 18, 2018

MDD Trial in Worldwide (Placebo, Cariprazine)

Completed
  • Major Depressive Disorder
  • Garden Grove, California
  • +71 more
Mar 29, 2018

MDD Trial in Worldwide (LY2216684, Placebo, SSRI)

Completed
  • Major Depressive Disorder
  • Garden Grove, California
  • +48 more
Mar 26, 2018

MDD Trial in Romania, United States (LY2216684, Placebo, Escitalopram)

Completed
  • Major Depressive Disorder
  • Orlando, Florida
  • +6 more
Mar 26, 2018

MDD Trial in United States (vilazodone)

Completed
  • Major Depressive Disorder
  • Garden Grove, California
  • +37 more
Aug 22, 2017

MDD Trial in Chile, United States (DVS SR)

Completed
  • Major Depressive Disorder
  • DVS SR
  • Birmingham, Alabama
  • +35 more
Jun 28, 2017

MDD Trial in Worldwide (AZD6765 iv, Placebo)

Completed
  • Major Depressive Disorder
  • AZD6765 iv
  • Placebo
  • Chino, California
  • +43 more
Apr 10, 2017

MDD Trial in Chile, Mexico, United States (Desvenlafaxine Succinate Sustained-Release, Placebo)

Completed
  • Major Depressive Disorder
  • Desvenlafaxine Succinate Sustained-Release
  • Placebo
  • Birmingham, Alabama
  • +41 more
Jan 30, 2017